Skip to main content
finq
OS
Search ticker, company, or fund...
⌘
K
Capture
Closed
SNDX: Syndax Pharmaceuticals, Inc. Stock Analysis | finqOS
Healthcare · Biotechnology
The Story
SNDX
The Story
SNDX
Loading chart data...
Current State
Balance holding
The verdict
Good business
Weak
Revenue growth
+0.0% / yr
Operating margin
-102.9%
ROIC
-57.8%
Financially safe
Stretched
Debt / equity
8.30×
Interest coverage
-2.8×
Current ratio
5.47×
Syndax Pharmaceuticals, Inc.
SNDX
NASDAQ Global Select
·
USD
·
Closed
Story
Data
Canvas
Capture
Save
Syndax Pharmaceuticals, Inc.
SNDX
NASDAQ
·
USD
·
Closed
$19.05
−2.21%
$19.05
−$0.43 (2.21%)
52W Range
59th
pctl
Volume
0.61×
avg
Mkt Cap
1.69B
USD
P/E
-6.8
TTM
Div Yield
–
ann
52W Range
59th
pctl
Volume
0.61×
avg
Market Cap
1.69B
USD
P/E Ratio
-6.8
TTM
Div Yield
-
ann
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings